Patent · US Active

Preparation of protective antigen

US8323927B2 · kind B2 · utility

2Cited by
3References
19Claims
0Family size

Assignees

Inventors

Key dates

Filing dateSep 27, 2011
Grant dateDec 4, 2012
Priority date
Expiry dateSep 27, 2031

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K2039/53
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A polynucleotide sequence is provided comprising a nucleic acid sequence encoding recombinant Protective Antigen (rPA).Also provided are expression vectors and host cells comprising the polynucleotide sequence of the invention, and methods for producing rPA.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.